LARIMAR THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $3.2M | $121.7M | $32.4M |
| FY2017 | $20.0M | $78.2M | $40.8M |
| FY2018 | $20.0M | $2.9M | $49.3M |
| FY2019 | $14.5M | $-694.0K | $1.0M |
| FY2020 | — | $89.7M | $68.1M |
| FY2021 | — | $64.4M | $70.1M |
| FY2022 | — | $110.9M | $26.8M |
| FY2023 | — | $81.7M | $26.7M |
| FY2024 | — | $171.8M | $33.2M |
| FY2025 | — | $78.1M | $85.4M |